GALECTIN THERAPEUTICS INC
GALT · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Uihlein Richard E: Form 4
Insider disclosure · Filed · Report period 31 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- GALT · 363225202 - COMMON STOCK
Company details and SEC sources
CIK 0001133416 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GALT on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, 30071
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- PRO PHARMACEUTICALS INC (to 26 May 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields